Celebrating International Clinical Trials Day with our patients and families
21 Jun 2023, 11 a.m.
At Great Ormond Street Hospital (GOSH), we embed research and innovation in everything that we do, improving the care we can deliver to children with rare and complex diseases. A big part of that research is our portfolio of clinical trials.
On 19 May we enjoyed welcoming patients, their families and GOSH staff, including GOSH nursery to the Lagoon to celebrate International Clinical Trials Day as well as the National Institute for Health and Care Research (NIHR) “Be Part of Research campaign that aims to raise awareness of research.
Our interactive activity hub in the Lagoon welcomed over 50 visitors who met research staff, shared their stories and joined in our fun research engagement activities.
Families were able to visit our laboratory stall to study slides under a microscope or practise their pipetting skills. Children were also able to put on our junior nurses’ uniforms, or GOSH lab coats and learn about the role of our research nurses through play and art activities.
GOSH teams also used the event to run a “mock chocolate trial” – walking families through a randomised controlled clinical trial, from start to finish!
We’d like to thank all of the research and research nursing staff who took part in leading activities.
Contact us to find out more about Patient and Public Involvement opportunities at GOSH.
Reducing oxygen levels for children in intensive care will save lives
A new landmark study led from GOSH has found that reducing oxygen levels for critically ill children on mechanical ventilators in intensive care could save lives
GOSH to provide support for AI and Machine Learning as part of new paediatric HealthTech Research Centre
GOSH will support the new Child and Young People’s HealthTech Research Centre (HRC), led by Sheffield Children’s Hospital, as leads for AI and Machine Learning.
Clinical trial results give new hope for children with rare brain tumours
Researchers who are searching for better treatments for an incredibly rare type of brain tumour have published successful results from the latest rounds of clinical trials.
GOSH receives new MHRA authorisation to manufacture viral vectors
GOSH has been granted a Manufacturer's Authorisation Licence for the manufacture of viral vectors, which will accelerate Cell and gene therapies (CGT) clinical trials worldwide and expand the novel treatments that we can offer to our patients.